Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-07

Clinical Trial Update: Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c [Phase 3]

View source ↗

Summary

A Phase 3 randomized controlled trial evaluated whether cinnamon lowers hemoglobin A1c in individuals with diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cinnamon (cinnamon)

Snippet

Sponsor: Eglin AFB Regional Hospital | Conditions: Diabetes | Phase 3 | Status: COMPLETED